| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |